How Does AI Understand LEQEMBI (Eisai / Biogen)? Discover the Brand’s Strengths, Weaknesses and Industry Position

AI only sees the HTML that arrives on first response — everything else is invisible. Expose your real text only footprint and find out which parts of your site never reach an AI crawler at all.

Transition from a collection of strings to a machine verifiable identity. Generate your Clinical SEO Strategy to establish a robust Knowledge Graph Topology and eliminate semantic black holes.

Trust theatre is present primarily through the heavy use of compensated patient testimonials. While the site provides a review_count of 15 on the patient stories page, these are not independent reviews but curated marketing narratives, explicitly stating patients were ‘compensated for their time’. The proof_links_count is 1 per page, typically pointing to the Full Prescribing Information (PI), but there is a lack of direct outbound links to the peer-reviewed publications (e.g., NEJM) in the primary body text. This creates a closed-loop proof environment where the drug manufacturer is the primary source of the evidence presented.

The proof density is high for a commercial site, citing specific study numbers (1,795 people) and tools (Clinical Dementia Rating scale). However, the ratio is diluted by the volume of patient quotes from 10+ named individuals who were compensated, which shifts the weight from scientific proof to anecdotal ‘Patient Stories’. The evidence of ‘maintenance dosing’ is backed by specific FDA-approved schedule changes (once-weekly at-home vs once-monthly infusions), providing concrete substance to the service delivery model.

To review a full competitive diagnostic applied to an enterprise level technical SEO agency, including a direct comparison against Dejan, examine the complete executive audit. View the iPullRank Executive SEO Strategy Dashboard for a practical example of how perception gaps, value prop drift, and audience misalignment are surfaced in real audits.

There is a significant technical authority gap due to the total absence of schema_json (null) across all pages, which is unexpected for a top-tier pharmaceutical brand. While the product authority is established by FDA references, there is no structured Person schema for the researchers or medical experts involved in the studies. The technical implementation lacks the structured data footprint necessary to verify expert identities through sameAs links or organizational hierarchy in a machine-readable format.

The marketing tone is highly optimistic (‘You Still Can Be’), which slightly disconnects from the clinical reality of ‘significantly slowing’ rather than reversing or stopping the disease. The site acknowledges this in small print (‘Even though you cannot stop Alzheimer’s…’), but the visual and heading narrative pushes a much stronger performance claim. The use of icons for ‘Remembering’ and ‘Problem-solving’ suggests a broader impact that the text then admits was not individually proven in the study.

The site perfectly matches the Pharma and Biotech industry, focusing on a specific FDA-approved therapeutic (lecanemab-irmb) for Alzheimer’s disease. It adheres to regulatory requirements including the prominent Boxed Warning and Important Safety Information (ISI).

When links fail to express hierarchy, the model cannot form clusters or identify primary entities. Examine the Internal Linking Technical Guide and understand how structural signals—not navigation—define your semantic map.

“The score is primarily driven by Information Density (power words vs specific nouns) and Identity/Authority (lack of schema). The site's near-perfect Semantic Coherence score reflects a very disciplined marketing strategy that avoids contradictory claims, which is typical of highly regulated medical products.”